CompletedNCT04417673

Living With Sickle Cell Disease in the COVID-19 Pandemic

Studying Sickle cell disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Human Genome Research Institute (NHGRI)
Principal Investigator
Ashley J Buscetta, C.R.N.P.
National Human Genome Research Institute (NHGRI)
Enrollment
186 enrolled
Eligibility
18 years · All sexes
Timeline
20202022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04417673 on ClinicalTrials.gov

Other trials for Sickle cell disease

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell disease

← Back to all trials